Nasdaq & Equities
SEC EDGAR
Moleculin Biotech, Inc. files a Form 8-K with the SEC
Moleculin Biotech, Inc.'s filing reports changes among directors or senior officers and shareholder vote results.
Live alert: the SEC EDGAR has published a new official document. Read the full original at the source link; ForCryptoNews has not reproduced its text and does not interpret its market impact.
Source: SEC EDGAR, official website. Licence: Public domain (U.S. Government): https://www.sec.gov/privacy#dissemination
Educational information. Not investment advice.
Primary source
Educational information. Not investment advice.